PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients Assessment of the Correlation Between Body Mass Index and Recurrence Among Zoladex Treated Prostate Cancer Patients
Phase of Trial: Phase IV
Latest Information Update: 29 Apr 2013
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms PROTECT-Z
- Sponsors AstraZeneca
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 May 2012 Planned end date changed from 1 Feb 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 18 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.